To clarify your point re: Gen 2 and particularly Gen 3.
The new combination single pill alone cured around 70% of these patients.
However, with the addition of Ribavirin the response rate was 100%.
G3 and relapsers, together with certain subtypes, will go twelve weeks instead of eight AND use Ribavirin. IMO the other combos are not in the race until they can supply a once per day six/eight week course.
Gen 1 is far and away the most common variant in the west.
- Forums
- ASX - By Stock
- BLT
- Hep C - adherence issues
Hep C - adherence issues, page-6
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)